niklas finnberg
Medivir (Sweden)
Huddinge, Sweden
Associate Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial Board
Type at least 3 characters
669 editors
Shape the future of research in your field
Join the board
Editors
Associate Editors
ka-wing fong
University of Kentucky
Lexington, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
liwu fu
Sun Yat-sen University Cancer Center (SYSUCC)
Guangzhou, China
Associate Editor
Cancer Molecular Targets and Therapeutics
tomofusa fukuyama
Department of Hematology, International University of Health and Welfare Hospital
Tochigi, Japan
Associate Editor
Cancer Molecular Targets and Therapeutics
laura gatti
IRCCS Carlo Besta Neurological Institute Foundation
Milan, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
shanmugasundaram ganapathy-kanniappan
School of Medicine, University of Maryland
Baltimore, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
tomas garzon-muvdi
Jefferson University Hospitals, Thomas Jefferson University
Philadelphia, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
susanne andrea gatz
Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham
Birmingham, United Kingdom
Associate Editor
Cancer Molecular Targets and Therapeutics
navnath s gavande
Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University
Detroit, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
silvia giordano
University of Turin
Turin, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
alessio giubellino, md phd
University of Minnesota Health Sciences, University of Minnesota Medical Center
Minneapolis, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
daniel e. gomez
National University of Quilmes
Bernal, Argentina
Associate Editor
Cancer Molecular Targets and Therapeutics
mamta gupta
George Washington University
Washington, D.C., United States
Associate Editor
Cancer Molecular Targets and Therapeutics
shiv k gupta
Mayo Clinic
Rochester, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
xin hong
Southern University of Science and Technology
Shenzhen, China
Associate Editor
Cancer Molecular Targets and Therapeutics
hasem habelhah
The University of Iowa
Iowa City, United States
Associate Editor
Cancer Molecular Targets and Therapeutics